13F HOLDINGS REPORT
TAKEDA PHARMACEUTICAL CO LTD
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0001395064-25-000030
Total Value
$38.0M
Positions
12
Other Managers
1
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HilleVax, Inc. | 43157M102 | 6,724,000 | $11.8M | 31.18% |
| 2 | Wave Life Sciences Ltd. | WVE | 1,096,892 | $9.0M | 23.70% |
| 3 | Ovid Therapeutics Inc. | OVID | 5,750,000 | $6.8M | 17.88% |
| 4 | Ovid Therapeutics Inc. | OVID | 1,781,996 | $2.1M | 5.54% |
| 5 | Wave Life Sciences Ltd. | WVE | 250,000 | $2.0M | 5.40% |
| 6 | Shattuck Labs, Inc. | STTK | 515,619 | $1.8M | 4.74% |
| 7 | Equillium, Inc. | EQ | 1,824,977 | $1.5M | 3.99% |
| 8 | Xilio Therapeutics, Inc. | XLO | 1,475,121 | $1.2M | 3.06% |
| 9 | American Well Corp | AMWL | 77,733 | $736,913 | 1.94% |
| 10 | Turnstone Biologics Corp. | 90042W100 | 895,824 | $498,974 | 1.31% |
| 11 | Rani Therapeutics Holdings, Inc. | RANI | 203,190 | $438,890 | 1.16% |
| 12 | STANDARD BIOTOOLS INC. | LAB | 16,515 | $31,874 | 0.08% |